NCT06229184View on ClinicalTrials.gov

Can Fecal Calprotectin Be Used as a Biomarker of Non-alcoholic Fatty Liver Disease In Obese Adolescents?

NACompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

November 16, 2022

Primary Completion Date

August 10, 2023

Study Completion Date

August 10, 2023

Conditions
Obesity, ChildhoodNAFLD
Interventions
DIAGNOSTIC_TEST

Fecal Calprotectin Test

Fecal samples are taken fom obese and healthy adolescents for study

Trial Locations (1)

Unknown

Sisli Hamidiye Etfal Training and Research Hospital, Istanbul

All Listed Sponsors
lead

Sisli Hamidiye Etfal Training and Research Hospital

OTHER